Clinical Effect Analysis of Letrozole on Preventing Ovarian Hyperstimulation after Oocyte Retrieval

张玲,李萍,林津,何雪梅,施迎迎,叶雅萍,沙艳伟,苏志英
2017-01-01
Abstract:Objective:To explore the clinical effect of oral letrozole on preventing ovarian hyperstimulation (OHSS) in the high-risk population of OHSS after egg retrieval procedure.Methods:Retrospectively analyzing clinical data of 621 high-risk patients of OHSS in vitro fertilization cycles,who were conducted IVF/ICSI with ultra-long GnRH-a protocol or long GnRH-a protocol,and were prepared for embryo cryopreservation after oocyte retrieval in our hospital from Nov.2011 to May.2016.All patients were divided into 2 groups,298 patients who were not treated with oral letrozole after oocyte retrieval were defined as group1,and the other 323 patients treated with oral administration of letrozole after oocyte retrieval were defined as group2.The pregnancy prognosis and incidences of total and moderate/severe OHSS were compared between two groups.Results:With the treatment of oral letrozole,the incidence of total and moderate/severe ovarian hyperstimulation in group 2 was 15.17% and 4.64%,respectively,both significantly lower than those in group1 (P <0.05).There was no significant difference between two groups about dosage and duration of GnRH,the level of LH,E2 and P,and ovulation rate in day of HCG injection (P > 0.05).Conclusions:Oral Letrozole can reduce the incidence of total OHSS and moderate/severe OHSS in the high-risk population of OHSS after oocyte retrieval.Letrozole can be used as clinical treatment for the prevention of OHSS.
What problem does this paper attempt to address?